# EDGAR Filing Document

**Accession Number:** 0001020214
**File Stem:** 0000950170-25-083561
**Filing Date:** 2025-6
**Character Count:** 7590
**Document Hash:** 713a2401f6f71788a13b9b7bd9db1cd5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-083561.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0000950170-25-083561

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 10

**CONFORMED PERIOD OF REPORT**: 20250603

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CERUS CORP
- **CENTRAL INDEX KEY:** 0001020214
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 680262011
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21937
- **FILM NUMBER:** 251033472

**BUSINESS ADDRESS:**
- **STREET 1:** 1220 CONCORD AVENUE
- **STREET 2:** SUITE 600
- **CITY:** CONCORD
- **STATE:** CA
- **ZIP:** 94520
- **BUSINESS PHONE:** 9252886000

**MAIL ADDRESS:**
- **STREET 1:** 1220 CONCORD AVENUE
- **STREET 2:** SUITE 600
- **CITY:** CONCORD
- **STATE:** CA
- **ZIP:** 94520

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CERUS TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19960731

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549** 

------

**FORM** 8-K

------

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934** 

**Date of Report (Date of earliest event reported):** June 3, 2025

------

Cerus Corporation

**(Exact name of Registrant as Specified in Its Charter)** 

------

---

| | | |
|:---|:---|:---|
| Delaware | 000-21937 | 68-0262011 |
| **(State or Other Jurisdiction**<br>**of Incorporation)** | **(Commission File Number)** | **(IRS Employer**<br>**Identification No.)** |
| 1220 Concord Ave., Suite 600<br>Concord**,** California |  | 94520 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: (**925**)** 288-6000

**Not Applicable** 

**(Former Name or Former Address, if Changed Since Last Report)** 

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | CERS | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

(e) On June 3, 2025, the stockholders of Cerus Corporation (the "Company") approved an amendment and restatement of the Company's 2024 Equity Incentive Plan (the "2024 Equity Incentive Plan"). The material terms of the 2024 Equity Incentive Plan are described in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 23, 2025 (the "Proxy Statement"), in the section entitled "Proposal No. 2 – Amendment and Restatement of the Company's 2024 Equity Incentive Plan" on pages 22 to 35, which description is incorporated herein by reference.

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

On June 3, 2025, the Company held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The following is a brief description of each matter voted upon at the Annual Meeting, as well as the number of votes cast for or against each matter and the number of votes withheld, abstentions and broker non-votes with respect to each matter, as applicable. A more complete description of each matter is set forth in the Proxy Statement.

**Proposal 1**

The Company's stockholders elected each of the two nominees named below to the Board of Directors to serve until the 2028 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Nominee** | &nbsp;&nbsp;**For** | &nbsp;&nbsp;**Withheld** | &nbsp;&nbsp;**Broker Non-Votes** |
| &nbsp;&nbsp;Jami Dover Nachtsheim | &nbsp;&nbsp;107020992 | &nbsp;&nbsp;7011149 | &nbsp;&nbsp;44116421 |
| &nbsp;&nbsp;Hua Shan, MD, Ph.D. | &nbsp;&nbsp;111424285 | &nbsp;&nbsp;2607856 | &nbsp;&nbsp;44116421 |

---

**Proposal 2**

The Company's stockholders approved amendment and restatement of the Company's 2024 Equity Incentive Plan.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**For** | &nbsp;&nbsp;**Against** | &nbsp;&nbsp;**Abstain** | &nbsp;&nbsp;**Broker Non-Votes** |
| &nbsp;&nbsp;74,344,720 | &nbsp;&nbsp;39,504,222 | &nbsp;&nbsp;183,199 | &nbsp;&nbsp;44,116,421 |

---

**Proposal 3**

The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**For** | &nbsp;&nbsp;**Against** | &nbsp;&nbsp;**Abstain** | &nbsp;&nbsp;**Broker Non-Votes** |
| &nbsp;&nbsp;104,504,639 | &nbsp;&nbsp;9,321,156 | &nbsp;&nbsp;206,346 | &nbsp;&nbsp;44,116,421 |

---

**Proposal 4**

The Company's stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for its fiscal year ending December 31, 2025.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**For** | &nbsp;&nbsp;**Against** | &nbsp;&nbsp;**Abstain** |
| &nbsp;&nbsp;153,189,590 | &nbsp;&nbsp;4,332,938 | &nbsp;&nbsp;626,034 |

---

No other matters were submitted for stockholder action at the Annual Meeting.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

------

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| &nbsp;&nbsp;Dated: June 9, 2025<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CERUS CORPORATION**<br>By: <u>/s/ Chrystal N. Jensen</u><br>Chrystal N. Jensen<br>Chief Legal Officer and General Counsel <br>|

---

------